Our project portfolio in pharma and biotech strategy is expansive. Our capabilities span all stages of the product lifecycle — from early-stage opportunity assessments to inform where a product’s greatest value may lie, to comprehensive launch planning and support.
We additionally support clients in setting strategy at the franchise and corporate level — including therapeutic area strategy, licensing and acquisitions, and corporate growth strategy. We have worked in every therapeutic area, and in both developed and emerging markets.
We work with organizations big and small, from top ten pharma companies to early startups. While the solutions should be right sized for the organization, our commitment to an exceptional project experience applies to all.
We are solving the problems at new frontiers for pharma. Below, explore a few examples that spotlight our recent work.
MOA Mapping and Prioritization
Product Profile Development
Patient Journey Assessment
Patient & Prescriber Segmentation
Global Launch Sequencing
Therapeutic Area Assessment
Corporate Growth Strategy
Asset Screening and Diligence
Buy- and Sell-side Due Diligence